CCCC vs HRL · rev $12.8M vs P/E 29, rev $8.96B
C4 Therapeutics Inc (CCCC) versus Hormel Foods Corporation (HRL) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Hormel Foods Corporation (HRL) is a packaged foods company listed on NYSE.
Latest reported CCCC revenue for 2026-06-30 was $12.8M. Net income was -$48.8M. CCCC currently screens at market cap $425.7M.
Latest reported HRL revenue for 2026-07-26 was $8.96B. Net income was $398.8M. Revenue was up 49.4% from 2026-04-26 to 2026-07-26. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
CCCC currently screens at market cap $425.7M. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
Not investment advice. Open the CCCC and HRL stock pages for the full models.
Not investment advice.